Hereditary Nonpolyposis Colorectal Cancer

Links shared publicly online about this topic

Hereditary Colorectal Cancer: eMedicine Gastroenterology

emedicine.medscape.com — “Overview: INTRODUCTION Hereditary nonpolyposis colorectal cancer (HNPCC), an autosomal-dominant syndrome, accounts for 2-5% of all colorectal carcinomas. Colorectal cancer in patients with hereditary nonpolyposis colorectal cancer (HNPCC) presents at an earlier age than in the general population and ...View full resource at emedicine.medscape.com

  • View Related
  • Share

Most Recently Shared on May 11, 2010 at 3:34 pm By:

SusanS_Health Susan Scroggins Active Health Library and Health Advocate

Hereditary nonpolyposis colorectal cancer accounts for 2-5% of all colorectal carcinomas. Learn more. http://bit.ly/9laadK

2 years ago...

Oncology Article | Alcohol Drinking Colorectal Neoplasms History Smoking Colorectal Neoplasms, Hereditary Nonpolyposis Survival

mdlinx.com — “Prediagnostic smoking history, alcohol consumption, and colorectal cancer survivalView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on April 20, 2011 at 12:10 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Prediagnostic smoking history, alcohol consumption, and colorectal cancer survival: Cancer http://bit.ly/fmn3Ni #oncology

1 year ago...

Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer -- Hitchins and Ward 46 (12): 793 -- Journal of Medical Genetics

jmg.bmj.com — “Hitchins, M P; Ward, R LView full resource at jmg.bmj.com

  • View Related
  • Share

Most Recently Shared on December 2, 2009 at 2:53 am By:

MarkRobsonMD Mark Robson Physician, Doctor, Internist, Oncologist, and Hematologist

Constitutional (germline) MLH1 epimutation as an aetiological mechanism for hereditary non-polyposis colorectal cancer http://bit.ly/4CKtz2

2 years ago...

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial : The Lancet

thelancet.com — “Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. By - Prof Sir John Burn MD, Prof Anne-Marie Gerdes MD...View full resource at thelancet.com

  • View Related
  • Share

Most Recently Shared on October 31, 2011 at 7:39 pm By:

Hereditary colorectal cancer diagnostics: morphological features of familial colorectal cancer type X versus Lynch syndrome -- Klarskov et al. 65 (4): 352 -- Journal of Clinical Pathology

jcp.bmj.com — “Hereditary colorectal cancer diagnostics: morphological features of familial colorectal cancer type X versus Lynch syndrome -- Klarskov et al. 65 (4): 352 -- Journal of Clinical PathologyView full resource at jcp.bmj.com

  • View Related
  • Share

Most Recently Shared on March 20, 2012 at 7:02 pm By:

ColonCancer_OW Colon Cancer OW OW Health

Hereditary colorectal cancer diagnostics: morphological features of familial colorectal cancer type X versus Lyn... http://t.co/SNyzByH9

2 months ago...

Aspirin reduces colorectal cancer rates by around 60% in those with increased hereditary risk http://t.co/rgHjCoUE

download.thelancet.com — “Aspirin reduces colorectal cancer rates by around 60% in those with increased hereditary risk http://t.co/rgHjCoUEView full resource at download.thelancet.com

  • View Related
  • Share

Most Recently Shared on October 28, 2011 at 1:32 pm By:

TheLancet The Lancet Medical Journal

Aspirin reduces colorectal cancer rates by around 60% in those with increased hereditary risk http://t.co/rgHjCoUE

7 months ago...

Video: DNA discovery opens new door to develop therapies for hereditary cancers

labspaces.net — “By solving the three-dimensional structure of a protein involved in repairing DNA errors, a group of McMaster University researchers have revealed new avenues to develop assessment tools and alternative treatments for people living with hereditary colorectal cancers.View full resource at labspaces.net

  • View Related
  • Share

Most Recently Shared on July 8, 2010 at 4:58 pm By:

LabSpaces Brian Krueger Health News

Video: DNA discovery opens new door to develop therapies for hereditary cancers - http://is.gd/dkeli

2 years ago...

Colorectal cancer risk halved by aspirin in study - HealthPop - CBS News

cbsnews.com — “Study shows daily aspirin use lowers cancer threat posed by rare hereditary disorder Read more by David W Freeman on CBS News' HealthPop.View full resource at cbsnews.com

  • View Related
  • Share

Most Recently Shared on October 28, 2011 at 6:28 pm By:

Lynch syndrome: Identifying patients at risk for HNPCC - ONA

oncologynurseadvisor.com — “Hereditary nonpolyposis colorectal cancer is caused by an inherited genetic mutation. This review explains how to screen and counsel patients at risk.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on March 16, 2011 at 2:35 pm By:

Aspirin associated with colorectal cancer prevention in Lynch syndrome | HemOncToday

hemonctoday.com — “Administering two aspirin per day to patients with hereditary bowel cancer reduced their risk for colorectal cancer by more than half within 5View full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on October 28, 2011 at 3:07 pm By:

HemOncToday HemOnc Today Oncology and Health News

#Aspirin associated with colorectal #cancer prevention in Lynch syndrome http://t.co/9whrwFx7

7 months ago...

DNA Discovery Opens New Door To Develop Tools, Therapies For Hereditary Cancers

medicalnewstoday.com — “By solving the three-dimensional structure of a protein involved in repairing DNA errors, a group of McMaster University researchers have revealed new avenues to develop assessment tools and alterView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on July 9, 2010 at 3:06 pm By:

mnt_biology MNT Biology News Health News

DNA Discovery Opens New Door To Develop Tools, Therapies For Hereditary Cancers http://mnt.to/3FSG #biology

2 years ago...

New test targets Lynch syndrome, a risk factor for colon cancer

sciencedaily.com — “Researchers have developed a screening procedure that could dramatically increase testing for Lynch syndrome, a hereditary genetic disorder that raises cancer risk, particularly for colorectal cancer.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on June 2, 2011 at 3:49 pm By:

hopkinscrc Hopkins Colon Cancer Hospital

New test targets Lynch syndrome, a risk factor for colon cancer http://bit.ly/iHVQim

12 months ago...

Test Targets Lynch Syndrome, a Risk Factor for Colon Cancer

newswise.com — “Mayo Clinic has developed a screening procedure that could dramatically increase testing for Lynch syndrome, a hereditary genetic disorder that raises cancer risk, particularly for colorectal cancer.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on May 18, 2011 at 3:57 pm By:

mednewswise Thom Canalichio Health News

Test Targets Lynch Syndrome, a Risk Factor for Colon Cancer: Mayo Clinic has developed a screening proce... http://bit.ly/j9pR87 #cancer

1 year ago...

Test Targets Lynch Syndrome, a Risk Factor for Colon Cancer

newswise.com — “Mayo Clinic has developed a screening procedure that could dramatically increase testing for Lynch syndrome, a hereditary genetic disorder that raises cancer risk, particularly for colorectal cancer.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on May 18, 2011 at 4:36 pm By:

mednewswise Thom Canalichio Health News

#health news: Test Targets Lynch Syndrome, a Risk Factor for Colon Cancer: Mayo Clinic has developed a screening... http://bit.ly/jgroGa

1 year ago...

Brupbacher Prize goes to B. Vogelstein and J. Hoeijmakers for research on colorectal and skin cancer

eurekalert.org — “Today, the Charles Rodolphe Brupbacher Prize for Cancer Research 2011 goes to two researchers who have contributed to better understanding of the genetics underlying the growth of tumors. Oncologist Bert Vogelstein has demonstrated how sequential accumulation of mutations leads to colorectal cancer, and Jan H. Hoeijmakers has conducted breakthrough research in xeroderma, a hereditary disease causing skin cancer.View full resource at eurekalert.org

  • View Related
  • Share

Most Recently Shared on February 17, 2011 at 7:24 pm By:

SkinCancer_OW Skin Cancer OW OW Health

Brupbacher Prize goes to B. Vogelstein and J. Hoeijmakers for research on colorectal and skin cancer: ( Universi... http://bit.ly/dN7Rrx

1 year ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • SusanS_Health

    Susan Scroggins

    Passionate about sharing quality health resources for good health. Content curator and organizer at organizedwisdom.com.

    View Profile

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

  • MarkRobsonMD

    Mark Robson

    medical oncologist concentrating on clinical translation of germline genetics; opinions expressed here are my own, not my employer's

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390